Aquila Investment Management’s Idexx Laboratories IDXX Stock Holding History

Aquila Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,000	Closed	-$1.08M	–	70
2024 Q1	$1.08M	Hold	2,000	–	–	0.92%	48
2023 Q4	$1.11M	Buy	2,000 +1,000	+100%	+$469K	0.96%	51
2023 Q3	$437K	Sell	1,000 -1,000	-50%	-$499K	0.4%	77
2023 Q2	$1M	Sell	2,000 -1,000	-33%	-$479K	0.82%	57
2023 Q1	$1.5M	Sell	3,000 -1,000	-25%	-$479K	1.24%	32
2022 Q4	$1.63M	Buy	+4,000	New	+$1.55M	1.26%	28

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aquila Investment Management's IDXX Position: Q2 2024 in Review

Aquila Investment Management sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 2,000 shares — an estimated $1.08M sold.

Aquila Investment Management first reported a position in IDXX in Q4 2022 and held it in 6 quarters. The position peaked at $1.63M in Q4 2022. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

Aquila Investment Management reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
Aquila Investment Management sold 2,000 Idexx Laboratories shares in Q2 2024, an estimated $1.08M.
Aquila Investment Management first reported a position in Idexx Laboratories in Q4 2022 and held it in 6 quarters.
Aquila Investment Management's Idexx Laboratories position peaked at $1.63M in Q4 2022.
1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Aquila Investment Management's 13F filing for Q2 2024, filed 24 Jul 2024.